Vitamin C and vitamin D3 alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis

• 主要な著者: Qingling Chen (著者), Lili Zhao (著者), Ling Mei (著者), Xiaotong Zhao (著者), Ping Han (著者), Jie Liu (著者), Chao Meng (著者), Ruifang Li (著者), Rui Zhong (著者), Kai Wang (著者), Jia Li (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Previous studies have demonstrated that both vitamin C (VC) and vitamin D3 (VD3) have therapeutic potential against metabolic disorders, including obesity, diabetes, and metabolic-associated fatty liver disease (MAFLD). However, it is unclear whether VC supplementation is associated with...